Your session is about to expire
← Back to Search
Dietary Supplement for Obesity
N/A
Waitlist Available
Led By Veena K Ranganath, M.D., M.S.
Research Sponsored by Dr. Veena Ranganath
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 6 and 12 months
Awards & highlights
Study Summary
This study is evaluating whether a weight loss intervention will improve your rheumatoid arthritis disease activity.
Eligible Conditions
- Obesity
- Rheumatoid Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in DAS28
change in PDUS
Secondary outcome measures
MBDA
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Dietary SupplementExperimental Treatment2 Interventions
Group II: Dietary CounselingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whey Protein&Prebiotic Supplement
2016
N/A
~40
Dietary recommendations
2019
N/A
~150
Find a Location
Who is running the clinical trial?
Dr. Veena RanganathLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Veena Ranganath, MD, MSLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Veena K Ranganath, M.D., M.S.Principal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
40 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger